Knee osteoarthritis (OA) causes pain, stiffness, and limits mobility, impacting daily activities and quality of life. Arthrosamid is an innovative single-injection treatment using a polyacrylamide hydrogel that cushions the knee joint, reducing discomfort and enhancing movement. Studies indicate Arthrosamid offers safe, effective, and longer-lasting relief compared to traditional hyaluronic acid injections, improving physical function and confidence to stay active. Expert care from specialists like Professor Paul Lee ensures personalized treatment decisions for optimal outcomes. For those with knee OA seeking to regain comfort and mobility, Arthrosamid presents a promising therapeutic option.
Arthrosamid, a polyacrylamide hydrogel injection, offers an effective treatment for medial-compartment knee osteoarthritis, particularly addressing inner-knee pain and joint instability. With ultrasound-guided precision, it restores natural knee cushioning and lubrication, reducing friction and shock during movement. Clinical studies indicate Arthrosamid provides longer-lasting pain relief than traditional hyaluronic acid or steroid injections, especially in patients under 70 with moderate OA and healthy body weight. Performed by experts like Professor Paul Lee at MSK Doctors, this minimally invasive procedure enhances mobility and quality of life with minimal side effects. Suitable patients often experience significant improvement in pain and function, making Arthrosamid a promising option for managing persistent medial knee osteoarthritis symptoms.
